Dermatology

Scar treatment dependent on techniqueLaser-assisted topical steroid delivery for hypertrophic scars and keloids produces sustainable results, study shows.
Satisfying cosmetic safetyThe FDA has proposed regulating the cosmetic industry, says Dr. Zoe Diana Draelos in her monthly Dermatology Times column, "Cosmetic Conundrums." This month Dr. Draelos examines three key questions about cosmetic safety.
Comprehending cleanser developmentSoap has probably done more to improve world health than any prescription medication, says Dr. Zoe Diana Draelos in her monthly Dermatology Times column, "Cosmetic Conundrums."
When flushing is more than embarrassmentAcute or irregular flushing may signal a more serious health condition, say researchers who list 14 questions physicians should ask patients complaining about unusual flushing.
Herpes zoster rates stay steady with biologics in psoriasisStudy shows no significant difference in herpes zoster risk between psoriasis patients receiving systemic therapy and those not receiving systemic therapy.
The top 25 psoriasis authorsIn 2018 at just five days into the New Year, a search of PubMed revealed 86 new psoriasis studies. So, who is leading the pack?
Female dermatologists sued less often than male counterpartsAlthough most malpractice cases against dermatologists are abandoned, withdrawn or dismissed, communication with patients may minimize liability.
The artificial brain as doctor
The artificial brain as doctorNeural networks do pattern recognition just as a dermatologist would learn patterns and visual data. Computer accuracy rivals that of humans for classifying skin cancer. Deep neural networks and artificial intelligence may have a growing role in practice.
My EMR has been hacked. What should I do?Dr. Derm logged into his office computer system, only to find a ransom note from a hacker, asking for money in exchange for the safe return of his patients’ records. Who are these hackers? How do they gain access? What should Dr. Derm do?
A noteworthy margin of error in psoriasis?Dermatologists need to be aware of margin of error and related issues that can affect the results of biosimilar clinical trials, a study shows.